News - Page 89 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article MindMed Announces Compliance with Nasdaq Listing Requirements

MindMed Announces Compliance with Nasdaq Listing Requirements

Post published:September 15, 2022
Post category:Press Release

Read more about the article MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT AND ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT AND ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

Post published:September 15, 2022
Post category:Press Release

Read more about the article Sep 13, 2022, 16:50 ET
MINDCURE Announces Financial Results for Fiscal 2022

VANCOUVER, BC, Sept. 13, 2022 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company") today announced its financial results for the three and twelve months…

Sep 13, 2022, 16:50 ET MINDCURE Announces Financial Results for Fiscal 2022 VANCOUVER, BC, Sept. 13, 2022 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company") today announced its financial results for the three and twelve months…

Post published:September 15, 2022
Post category:Press Release

Read more about the article Psilera Receives First Patent Allowance for Transdermal Patch Formulations

Psilera Receives First Patent Allowance for Transdermal Patch Formulations

Post published:September 14, 2022
Post category:Press Release

Read more about the article Revive Therapeutics Announces Submission of Amended Phase 3 COVID-19 Study Protocol to FDA

Revive Therapeutics Announces Submission of Amended Phase 3 COVID-19 Study Protocol to FDA

Post published:September 14, 2022
Post category:Press Release

Read more about the article Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of Phase 1 First-In-Human Clinical Trial Plan for Its Lead Clinical Candidate, MSP-1014

Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of Phase 1 First-In-Human Clinical Trial Plan for Its Lead Clinical Candidate, MSP-1014

Post published:September 14, 2022
Post category:Press Release

Read more about the article Sunstone Therapies Collaborates with MAPS to Conduct Clinical Trial of MDMA-Assisted Therapy for PTSD

Sunstone Therapies Collaborates with MAPS to Conduct Clinical Trial of MDMA-Assisted Therapy for PTSD

Post published:September 14, 2022
Post category:Press Release

Read more about the article Small Pharma Enters Into Automatic Share Purchase Plan

Small Pharma Enters Into Automatic Share Purchase Plan

Post published:September 13, 2022
Post category:Press Release

Read more about the article Numinus provides update on acquisition integration and announces new client financing options

Numinus provides update on acquisition integration and announces new client financing options

Post published:September 13, 2022
Post category:Press Release

Read more about the article Nature Biotechnology Selects Delix Therapeutics as a Leading Biotech Start-Up

Nature Biotechnology Selects Delix Therapeutics as a Leading Biotech Start-Up

Post published:September 13, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.